Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
EJNMMI Physics|July 23, 2016
An automatic delineation method for bone marrow absorbed dose estimation in (89)Zr PET/CT studiesN E Makris, R Boellaard, C W Menke, et al.
Medical Physics|October 6, 2014
Validation of simplified dosimetry approaches in ⁸⁹Zr-PET/CT: the use of manual versus semi-automatic delineation methods to estimate organ absorbed dosesN E Makris, F H P van Velden, M C Huisman, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 15, 2008
[Cardiotoxicity of trastuzumab of significance in the adjuvant treatment of breast cancer]C W Menke-van der Houven van Oordt, H J M Fliervoet, C M P W Mandigers, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2020
[Prioritising breast cancer care during the corona crisis]Y A Civil, T P van Iersel, C W Menke-van der Houven van Oordt, et al.
Cancer Metastasis Reviews|July 12, 2017
Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysisE J van Helden, C W Menke-van der Houven van Oordt, M W Heymans, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2020
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation studyL H Mammatas, A S Zandvliet, M Rovithi, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 10, 2007
Pheochromocytoma mimicking an acute myocardial infarctionC W Menke-van der Houven van Oordt, Th B Twickler, F G M H van Asperdt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2018
Radiomics analysis of pre-treatment [<sup>18</sup>F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatmentE J van Helden, Y J L Vacher, W N van Wieringen, et al.
Hormones & Cancer|July 17, 2016
Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal NetworkM H T Ettaieb, J C Duker, R A Feelders, et al.
British Journal of Cancer|July 2, 2014
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastasesJ A C M Goos, A C Hiemstra, V M H Coupé, et al.
Pageof 2